Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05799781 · ClinicalTrials.gov registry record · NA
Two Way Crossover Closed Loop MPC vs Control IQ
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT05799781 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 29 participants.
The verdict
NCT05799781, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
An artificial pancreas (AP) is a control system for automatic insulin delivery. The investigators have implemented a missed meal bolus detection algorithm for use within an AP control system. If a meal is detected that was not reported by the user, the system shall calculate the amount of meal insulin that will be dosed and deliver that insulin. The investigators will test how well the new algorithm manages glucose compared to the participant's usual care including the tslim X2 pump with Control IQ enabled. This type of algorithm may improve glucose control for high risk patient populations.
Interventions
- DEVICE MPC closed-loop system
- DEVICE t:slim X2 pump with Dexcom G6 CGM and Control IQ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2023-03-13 |
| Est. Completion | 2025-01-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05799781
The ClinicalTrials.gov registry entry for NCT05799781 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MPC closed-loop system is the first listed.
NCT05799781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05799781 about?
NCT05799781 is a clinical study titled "Two Way Crossover Closed Loop MPC vs Control IQ". An artificial pancreas (AP) is a control system for automatic insulin delivery. The investigators have implemented a missed meal bolus detection algorithm for use within an AP control system. If a meal is detected that was not reported by the user, the system shall calculate the amount of meal insul...
What is the current status of trial NCT05799781?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2023-03-13. Estimated completion is 2025-01-28.
What interventions are being tested in trial NCT05799781?
The interventions under investigation include: MPC closed-loop system (DEVICE), t:slim X2 pump with Dexcom G6 CGM and Control IQ (DEVICE).
Who is sponsoring clinical trial NCT05799781?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.